Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 435 (1-2), 147-152
- https://doi.org/10.1016/0006-8993(87)91595-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- In Vitro and In Vivo Irreversible Blockade of Cortical S2 Serotonin Receptors by N‐Ethoxycarbonyl‐2‐Ethoxy‐1,2‐Dihydroquinoline: A Technique for Investigating S2 Serotonin Receptor RecoveryJournal of Neurochemistry, 1986
- Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockadeBrain Research, 1985
- Effect of aging on recovery of striatal dopamine receptors following n-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockadeLife Sciences, 1984
- The effect of chronic neuroleptic administration on cerebral dopamine receptor functionLife Sciences, 1983
- Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineLife Sciences, 1983
- Minireview A systematic study of the pharmacological activities of dopamine antagonistsLife Sciences, 1979
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Enhancement of the α receptor blocking action of N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) by aminesLife Sciences, 1970
- Pharmacology of EEDQ (N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline)Canadian Journal of Physiology and Pharmacology, 1969
- N-carboxylic acid esters of 1,2- and 1,4-dihydroquinolines. New class of irreversible inactivators of the catechol amine .alpha.-receptors and potent central nervous system depressantsJournal of the American Chemical Society, 1968